Zydus Lifesciences Ltd

ZYDUSLIFE
Health CarePharmaceuticals
MidcapWith a market cap of ₹36,532 cr, stock is ranked 127
Low RiskStock is 1.58x as volatile as Nifty
356.8518.10 (+5.34%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
MidcapWith a market cap of ₹36,532 cr, stock is ranked 127
Low RiskStock is 1.58x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
8.23
PB RatioPB Ratio
2.45
Dividend YieldDiv. Yield
0.70%
Sector PESector PE
33.53
Sector PBSector PB
4.83
Sector Div YldSctr Div Yld
0.83%

Forecast & RatingsDetailed Forecast 

56%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Zydus Lifesciences Ltd is an India-based life sciences company. The Company has a pipeline for Biologics and Vaccines.

Brands

Cadila

Pharmaceutical company

Zydus Cadila

Investor PresentationView older 

May 20, 2022

PDF
View Older Presentations

Brands

Cadila

Pharmaceutical company

Zydus Cadila

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

201920202021202213.3714.3715.1417.851.851.182.134.44
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Recording of Analysts/Institutional Investor Meet/Con. Call 
Announced OnMay 20, 2022

Zydus Lifesciences Limited has informed the Exchange about Recording of Analysts/Institutional Investor Meet/Con. Call | Download

Zydus Lifesciences Limited has informed the Exchange about Recording of Analysts/Institutional Investor Meet/Con. Call | Download

General updates 
Announced OnMay 20, 2022

Zydus Lifesciences Limited has informed the Exchange about Promoters Intention Letter to participate in Buyback | Download

Zydus Lifesciences Limited has informed the Exchange about Promoters Intention Letter to participate in Buyback | Download

Cash Dividend 
Ex. DateJul 28, 2021

Final • Div/Share: ₹ 3.5

See all events